- ►annals.org JM Goodrich, RA Bowden, L Fisher, C Keller, … - Annals of Internal Medicine, 1993 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To study the efficacy and toxicity of ganciclovir prophylaxis ... Cited by 388 - Related articles - All 3 versions
- ►annals.org DJ Winston, WG Ho, K Bartoni, C Du Mond, … - Annals of internal medicine, 1993 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Objective: To evaluate the efficacy and safety of ganciclovir for ... Cited by 246 - Related articles - All 3 versions
JM Goodrich, M Mori, CA Gleaves, C Du … - New England Journal of Medicine, 1991 - content.nejm.org BACKGROUND. Cytomegalovirus (CMV) infection is a major cause of morbidity and
mortality after allogeneic bone marrow transplantation. We conducted a
controlled trial of ganciclovir for the early treatment of CMV infection in ... Cited by 394 - Related articles - All 4 versions
- ►hematologylibrary.org [PDF] M Boeckh, TA Gooley, D Myerson, T … - Blood, 1996 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 376 - Related articles - BL Direct - All 4 versions
GM Schmidt, DA Horak, JC Niland, SR Duncan … - New England Journal of Medicine, 1991 - content.nejm.org BACKGROUND. Cytomegalovirus (CMV)-associated interstitial pneumonia is a major
cause of death after allogeneic bone marrow transplantation. We conducted a
controlled trial of ganciclovir in recipients of bone marrow transplants ... Cited by 384 - Related articles - All 4 versions
- ►hematologylibrary.org [PDF] H Einsele, G Ehninger, H Hebart, KM Wittkowski … - Blood, 1995 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 320 - Related articles - BL Direct - All 7 versions
HG Prentice, E Gluckman, RL Powles, P … - Lancet, 1994 - ncbi.nlm.nih.gov Cytomegalovirus (CMV) infection is a major cause of morbidity and mortality
after allogeneic bone marrow transplantation (BMT). Our aim was to study the
prophylactic effect of high-dose intravenous acyclovir given around the ... Cited by 165 - Related articles - BL Direct - All 3 versions
- ►hematologylibrary.org [PDF] CR Li, PD Greenberg, MJ Gilbert, JM Goodrich … - Blood, 1994 - bloodjournal.hematologylibrary.org . reserved Hematology; all rights Copyright 2007 by The American Society of
Suite 200, Washington DC 20036. semimonthly by the American Society of
Hematology, 1900 M St, NW, Blood (print ISSN 0006-4971, online ISSN ... Cited by 321 - Related articles - BL Direct - All 4 versions
JD Meyers, EC Reed, DH Shepp, M Thornquist, … - New England Journal of Medicine, 1988 - content.nejm.org Patients undergoing allogeneic bone marrow transplantation who are seropositive
for cytomegalovirus are vulnerable to serious cytomegalovirus infection,
presumably because of reactivation of latent endogenous virus and severe ... Cited by 279 - Related articles - All 4 versions
JD Meyers, N Flournoy, ED Thomas - The Journal of infectious diseases, 1986 - jstor.org THE JOURNAL OF INFECTIOUS DISEASES . VOL. 153, NO. 3 . MARCH 1986 (c) 1986 by
The University of Chicago. All rights reserved. 0022-1899/86/5303-0011$01.00 ... Risk Factors for Cytomegalovirus Infection after Human Marrow ... Cited by 542 - Related articles - All 3 versions
